Mangalam Organics Ltd AI Stock Analysis
Want to see IN:MANORG full AI Analyst Report?
Mangalam Organics Ltd (MANORG) AI Stock Analysis
Mangalam Organics Ltd
(NSE:MANORG)
The overall score is constrained by significant financial risks, primarily high leverage and negative cash flows, which overshadow improving profitability. Technicals are neutral, and valuation is fair but offers no catalyst. The company's turnaround is not yet reflected in its cash generation or balance sheet strength.
Mangalam Organics Ltd (MANORG) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 3.80B
- Dividend Yield
- ―
- Average Volume (3M)
- 615
- Price to Earnings (P/E)
- 18.8
- Beta (1Y)
- 1.06
- Revenue Growth
- 17.28%
- EPS Growth
- -10.19%
- Country
- India
- Employees
- 347
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
Mangalam Organics Ltd Business Overview & Revenue Model
Company Description
Mangalam Organics Limited, together with its subsidiaries, manufactures and sells chemicals for the industrial and consumer markets in India and internationally. The company offers terpene products, including camphor, camphene, dipentene, isobornyl a...
How the Company Makes Money
Mangalam Organics makes money primarily by manufacturing and selling terpene and turpentine-derived specialty chemicals to business customers. Its revenue is largely generated from (1) sale of core terpene chemicals (commonly including products such...
Mangalam Organics Ltd Financial Statement Overview
Summary
Financial performance is mixed. The Income Statement shows recovery with moderate revenue growth and a healthy gross margin, but the Balance Sheet is highly leveraged (debt-to-equity > 1.0) and Cash Flow is deeply negative, indicating significant financial risk and weak cash conversion.
Income Statement
58NeutralBalance Sheet
42NeutralCash Flow
35Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.55B | 6.23B | 5.30B | 4.94B | 4.93B | 4.91B |
| Gross Profit | 2.42B | 2.17B | 2.57B | 1.13B | 701.20M | 1.47B |
| EBITDA | 857.00M | 890.69M | 589.13M | 390.38M | -24.27M | 924.25M |
| Net Income | 207.96M | 257.56M | 125.97M | 42.86M | -272.25M | 537.43M |
Balance Sheet | ||||||
| Total Assets | 0 | 7.40B | 6.24B | 4.85B | 5.06B | 5.60B |
| Cash, Cash Equivalents and Short-Term Investments | 25.91M | 24.68M | 189.27M | 20.19M | 12.79M | 12.78M |
| Total Debt | 0 | 3.59B | 2.72B | 1.73B | 1.90B | 2.12B |
| Total Liabilities | -3.19B | 4.21B | 3.30B | 2.05B | 2.30B | 2.56B |
| Stockholders Equity | 3.19B | 3.19B | 2.93B | 2.81B | 2.76B | 3.04B |
Cash Flow | ||||||
| Free Cash Flow | -769.42M | -907.41M | -751.15M | 327.48M | 361.57M | -1.84B |
| Operating Cash Flow | -281.34M | -272.47M | -78.44M | 727.23M | 769.23M | -841.04M |
| Investing Cash Flow | -381.05M | -600.78M | -670.47M | -395.09M | -407.80M | -995.25M |
| Financing Cash Flow | 673.44M | 879.76M | 736.26M | -325.52M | -355.77M | 1.83B |
Mangalam Organics Ltd Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MANORG, the sentiment is Negative. The current price of 450.00 is below the 20-day moving average (MA) of 450.33, below the 50-day MA of 457.25, and below the 200-day MA of 474.20, indicating a bearish trend. The MACD of -3.96 indicates Positive momentum. The RSI at 44.86 is Neutral, neither overbought nor oversold. The STOCH value of 20.81 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:MANORG.
Mangalam Organics Ltd Peers Comparison
Overall Rating
IN:JAYAGROGN70Outperform
IN:AARTISURF66Neutral
IN:ROSSARI65Neutral
IN:CHEMCON61Neutral
IN:FAIRCHEMOR53Neutral
IN:MANORG48Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 70Outperform | INR 6.93B | 10.44 | ― | 1.54% | 18.12% | 27.74% | |
| 66Neutral | INR 4.20B | 23.82 | ― | 0.19% | 25.22% | 20.38% | |
| 65Neutral | INR 23.79B | 15.59 | ― | 0.12% | 19.76% | 11.74% | |
| 61Neutral | INR 7.31B | 25.01 | ― | 3.17% | 22.25% | 20.33% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 53Neutral | INR 8.73B | 36.44 | ― | 0.15% | 17.44% | 304.08% | |
| 48Neutral | INR 3.77B | 18.78 | ― | ― | 17.28% | -10.19% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:MANORG | Mangalam Organics Ltd | 450.00 | -90.50 | -16.74% | |
| IN:AARTISURF | Aarti Surfactants Ltd. | 520.75 | 65.88 | 14.48% | |
| IN:CHEMCON | Chemcon Speciality Chemicals Ltd | 204.55 | -25.54 | -11.10% | |
| IN:FAIRCHEMOR | Fairchem Organics Ltd | 688.15 | 53.11 | 8.36% | |
| IN:JAYAGROGN | Jayant Agro-Organics Limited | 228.05 | 12.36 | 5.73% | |
| IN:ROSSARI | Rossari Biotech Ltd | 429.05 | -200.39 | -31.84% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 06, 2026
